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Background: Identifying vulnerable coronary plaque with coronary CT angiography is
limited by overlap between attenuation of necrotic core and fibrous plaque. Using x-rays
with differing energies alters attenuation values of these components, depending on their
material composition.
Objectives: We sought to determine whether dual-energy CT (DECT) improves plaque
component discrimination compared with single-energy CT (SECT).
Methods: Twenty patients underwent DECT and virtual histology intravascular ultrasound
(VH-IVUS). Attenuation changes at 100 and 140 kV for each plaque component were
defined, using 1088 plaque areas co-registered with VH-IVUS. Hounsfield unit thresholds
that best detected necrotic core were derived for SECT (conventional attenuation values)
and for DECT (using dual-energy indices, defined as difference in Hounsfield unit values at
the 2 voltages/their sum). Sensitivity of SECT and DECT to detect plaque components was
determined in 77 segments from 7 postmortem coronary arteries. Finally, we examined 60
plaques in vivo to determine feasibility and sensitivity of clinical DECT to detect VH-IVUS
edefined necrotic core.
Results: In contrast to conventional SECT, mean dual-energy indices of necrotic core and
fibrous tissue were significantly different with minimal overlap of ranges (necrotic core,
0.007 [95% CI, e0.001 to 0.016]; fibrous tissue, 0.028 [95% CI, 0.016e0.050]; P < .0001). DECT
increased diagnostic accuracy to detect necrotic core in postmortem arteries (sensitivity,
64%; specificity, 98%) compared with SECT (sensitivity, 50%; specificity, 94%). DECTonflict of interest.
ior authors.
, United Kingdom, grants FS/10/025/28196, PG/08/008, and CH/2000003; the Academy of
he Higher Education Funding Council for England, United Kingdom (J.H.F.R.); and the NIHR
(M.R. Bennett).
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than SECT (45% vs 39%).
Conclusions: DECT improves the differentiation of necrotic core and fibrous plaque in
ex vivo postmortem arteries. However, much of this improvement is lost when translated
to in vivo imaging because of a reduction in image quality.
ª 2014 Society of Cardiovascular Computed Tomography. Open access under CC BY-NC-ND license1. Introduction SanDiego, CA) as described previously.8 CTdatawere acquiredRupture-prone coronary atherosclerotic plaques typically
have a large necrotic core and thin fibrous cap1; differentiation
of these features is therefore critical for imaging modalities to
identify potentially high-risk plaques. Although coronary CT
angiography (CTA) can identify some plaque features that
predict acute coronary syndrome, such as positive arterial
remodeling and low-attenuation areas of plaque,2 more pre-
cise identification requires better discrimination of these
components from each other. Plaque elements can be char-
acterized by their CT attenuation profiles; however, studies
that used conventional single-energy CT (SECT) found limiting
overlap of the attenuation ranges of necrotic core and fibrous
plaque.3,4
Tissue attenuationprofiles are determined both byphysical
properties of constituent elements (atomic number and den-
sity) and by delivered x-ray energy. For example, dual-energy
CT (DECT) provides differing attenuation of materials at 2
different energies and can differentiate fatty liver from tumor
or can determine the composition of renal stones.5,6 In theory,
DECT should further separate attenuation values of coronary
plaque components, allowing easier differentiation. Indeed,
2 separate sequential scans with different energies on ex vivo
coronaries showed that calcified plaques had the largest and
lipid-richplaques the least difference in attenuation onDECT.7
However, the ability ofDECT todifferentiate necrotic core from
fibrous tissue has never been tested. Furthermore, sequential
scanning cannot be used for rapidly moving coronary arteries,
and theability ofDECT to identifyplaquecomposition invivo is
unknown. The 2-tube, 2-detector configuration of dual-source
scanners allows acquisition of 2 temporally registered data
sets of different energies. We therefore determined whether
DECT could differentiate plaque components better than SECT
and to identify these components ex vivo against postmortem
histology and in vivo against virtual histology intravascular
ultrasound (VH-IVUS).2. Methods
2.1. Study protocol
The local institutional review board approved the entire study,
and participants gave fully informed consent. Subjects with
stable angina or acute coronary syndrome scheduled for
percutaneous coronary intervention underwent both VH-IVUS
and coronary CTA with data sets used initially for derivation
and then validation of DECT plaque analysis. VH-IVUS was
acquired with Eagle-Eye Gold catheters (Volcano Corporation,with a Somatom Definition 64-slice dual-source machine
(Siemens, Germany). Intravenous metoprolol was adminis-
tered if heart rate was >65 beats/min. Images were acquired
simultaneously at 140 kV, 82mAs (tubeA) and 100 kV, 164mAs
(tube B) with 64  0.6-mm collimation. A triphasic injection
protocol with intravenous contrast (iopamidol [Niopam 370];
Bracco, UK) was used after a 20-mL timing bolus.2.2. Co-registration of DECT and VH-IVUS plaque
components
CT image analysis was performed with Circulation III software
(Siemens). Curvedmultiplanar coronary artery reconstructions
were compared with longitudinal reconstructed IVUS data
sets. To facilitate plaque component sampling VH-IVUS was
used to identify plaque cross-sectional images that were either
predominantly fibrous plaque or contained a large confluent
necrotic core or dense calcification as previously described.9
These plaque locations were co-registered from IVUS to coro-
nary CTA by triangulation with the use of reference measure-
ments from coronary ostia and side branches (Fig. 1). Areas
of hypoattenuating or hyperattenuating plaque on cross-
sectional coronary CTA images were classified as necrotic
core, fibrous plaque, or calcifiedplaque, depending onmatched
corresponding VH-IVUS frames. Attenuation was sampled at 8
points distributed throughout these areas and lumen, to give
mean CT attenuation values (Hounsfield units) (Fig. 2). DECT
acquisition yielded 2 data sets with matching attenuation
values at different energies for each plaque component.2.3. Validation of necrotic core detection with DECT
2.3.1. Postmortem validation
The left anterior descending artery was dissected in 10
autopsy hearts within 24 hours of death with 40 to 50 mm of
surrounding tissue to maintain structural integrity. Vessels
were wax-embedded for mechanical support, and the left
main stem ostium and distal left anterior descending artery
were cannulated. Seven of 10 arteries were suitable for im-
aging (occluded arteries were not used). Vessels were sub-
merged and pressure-perfused with phosphate-buffered
saline at 37C at 100 mmHg. DECT acquisition was performed
with the same peak tube voltages as in vivo, using contrast
diluted to achieve luminal attenuation comparable with
in vivo scans.
After imaging, arteries were fixed with formalin, and
the external surface was marked at 1-cm intervals to aid
co-registration. Each 1-cm coronary artery block was cut into
segments 400 mm in length, processed for histology, sectioned
Fig. 1 e Co-registration between VH-IVUS and 140 kV/100 kV DECT. Longitudinal (left) and cross-sectional (right) images for
VH-IVUS and co-registered DECT at 100 kV and 140 kV. Calcified plaque is identified 5 mm from a side branch adjacent to
characteristic calcification ( yellow line). A cross section is taken through this plaque (blue arrow), and, after orientation with
the VH-IVUS cross-section region of interest, sampling to obtain Hounsfield unit was performed in the calcified plaque
(asterisk). Green indicates fibrous plaque; red, necrotic core; white, calcified plaque. DECT, dual-energy CT; HU, Hounsfield
unit; VH-IVUS, virtual histology intravascular ultrasound.
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and Movat’s pentachrome stains. A histopathologist (M.G.)
then identified any plaque areas that contained necrotic coreFig. 2 e Attenuation sampling of VH-IVUSedefined necrotic cor
sampling in hypoattenuated area of noncalcified plaque (B). (C)
contains significant necrotic core (red ). Green indicates fibrous
IVUS, virtual histology intravascular ultrasound.with no minimum cutoff size, as long as a confluent core was
discernable within the plaque. Sequential 400-mm segments
of coronary CTA images co-registered with histology weree. (A) Cross section of coronary CTA with attenuation
Co-registered VH-IVUS slice shows that sampled area
plaque; white, calcified plaque. CTA, CT angiography; VH-
Table 1 e Attenuation values (HU) of VH-IVUSedefined
plaque components at 100 kV and 140 kV.
Median Range 25%e75% 5%e95%
Necrotic core
100 kV 56 40 to 219 29e81 12 to 138
140 kV 42 20 to 121 22e64 5 to 98
Fibrous plaque*
100 kV 150 37 to 254 104e185 73 to 223
140 kV 82 39 to 178 60e106 41 to 147
Lumen*
100 kV 425 228 to 604 361e464 270 to 540
140 kV 276 179 to 417 243e325 196 to 380
Calcified plaque*
100 kV 716 305 to 1528 554e856 448 to 1207
140 kV 555 119 to 1189 439e696 333 to 990
HU, Hounsfield unit; VH-IVUS, virtual histology intravascular
ultrasound.
* Significant difference in the attenuation of plaque components at
100 kV and 140 kV (P < .05, Dunn’s multiple comparison test).
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to identify all visible coronary plaques. Attenuation was
sampled throughout all noncalcified plaque and identified as
necrotic core if any attenuation values were lower than the
threshold attributed to necrotic core. Matching attenuation
values were also sampled in the 140-kV data set and used to
create a dual-energy index (DEI) with the use of a formula used
previously7 which maximizes the difference in attenuation at
100 kV (x100) and 140 kV (x140) by dividing the difference in
Hounsfield unit values at the 2 peak voltages by their sum,
with individual attenuations shifted by 1000 HU to avoid
negative values.
DEI ¼ ðx100þ 1000 HUÞ  ðx140þ 1000 HUÞðx100þ 1000 HUÞ þ ðx140þ 1000 HUÞ
Plaquewas classified as necrotic core by DECT if the DEI was
in the range attributed to necrotic core.
2.3.2. Feasibility of clinical DECT
The image quality of all in vivo scans was assessed with
the following 4-point scoring system10: 1, nondiagnostic; 2,
adequate image quality to rule out significant stenosis but
significant artifact present; 3, good image quality with any
artifact present not interfering with assessment of calcified or
noncalcified plaque; and 4, excellent images with complete
absence of artifact. Image noise was defined as the standard
deviation of attenuation (HU) in a 5-mm2 sampled area placed
within the aortic root. Effective radiation doses were calcu-
lated with the standard organ weighting factor for the chest
(k ¼ 0.0014 mSv).
2.3.3. In vivo validation
VH-IVUS was performed in all 3 coronary arteries, and all
plaques detected in vivo were co-localized with equivalent
plaques on coronary CTA by using the triangulation method
(Fig. 1). Plaque was analyzed by coronary CTA frame by frame,
and attenuation was sampled throughout all noncalcified
plaques. Necrotic core was identified by SECT if any attenua-
tion values at 100 kV were lower than the threshold attributed
to necrotic core, and by DECT if the DEI was in the range
attributed to necrotic core. The accuracy of coronary CTA
to determine the presence of necrotic core was compared
with standard VH-IVUS definitions (plaque containing >10%
VH-IVUSedefined confluent necrotic core for 3 consecutive
frames11).
2.4. Statistical analysis
Statistical analysis was performed with R software (R Core
Team [2013]; R Foundation for Statistical Computing, Austria).
Continuous variables are presented asmeans SD if normally
distributed and medians [interquartile ranges] if not. Attenu-
ation values and DEIs were expressed as box and whisker
plots. Differences in plaque component attenuation and DEIs
were assessed with a linear mixed effects model (to account
for multiple values per patient) with plaque component and
kilovolt value as fixed effects, patient as a random effect, and
assuming a compound symmetry structure. Plaque compo-
nent was included in the model as an explanatory factor
variable with 4 levels (necrotic core, fibrous plaque, lumen,and calcified plaque) with necrotic core as the reference
category. Measurements of accuracy are expressed as point
estimates of sensitivity, specificity, and diagnostic accuracy.3. Results
3.1. Defining plaque components with DECT
We first established DECT attenuation ranges for plaque com-
ponents (defined by VH-IVUS). Twenty patients underwent
coronary CTA and 3-vessel VH-IVUS, and 1104 regions of
interest (ROIs)were sampled from138 plaque cross sections (69
at 100 kV and 69 at 140 kV), providing paired attenuation values
at 100 kV (552 ROIs) and 140 kV (552 ROIs) (95 necrotic cores, 85
fibrous tissues, 230 calcified plaques, and 142 lumens; Table 1).
Comparedwith necrotic core, lumen attenuationwas higher at
both100kV (meandifference, 350.9HU; 95%CI, 253.1e448.7HU)
and 140 kV (mean difference, 237.7 HU; 95%CI, 160.8e314.5HU;
P < .0001). Similar differences were found between calcified
plaque and necrotic core at both 100 kV (mean difference,
671.6HU; 95%CI, 582.7e760.5HU) and 140 kV (meandifference,
535.3 HU; 95% CI, 465.4e605.2 HU; P < .0001). However, neither
of the conventional single energies completely separated
fibrous plaque from necrotic core (mean difference at 100 kV,
107.8HU; 95%CI,0.19 to215.9HU;P¼ .05; andmeandifference
at 140 kV, 51.1 HU; 95% CI, 33.9 to 136.0 HU; P ¼ .233).
Tissue attenuation values are different at 100 kV and
140 kV, and this difference is greater for some plaque com-
ponents than others. To increase sensitivity of DECT to detect
differences in plaque components, we calculated their DEI as
previously defined.7 DEIs for each component were necrotic
core (0.007  0.006), fibrous plaque (0.028  0.011), lumen
(0.048  0.016), and calcified plaque (0.059  0.028). Impor-
tantly, DEIs of necrotic core were significantly different for
both fibrous plaque (mean difference, 0.023; 95% CI,
0.008e0.037) and calcified plaque (mean difference, 0.039; 95%
CI, 0.027e0.051; P < .0001). DEI ranges overlapped significantly
for lumen (0.028e0.081) and calcified plaque (0.013e0.096),
lumen and fibrous plaque (0.016e0.050), and fibrous plaque
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(0.001 to 0.016) did not overlap with any other component, in
contrast to the marked overlap of necrotic core and fibrous
tissue ranges with both single energies 100 kV (37e219 HU)
and 140 kV (39e121 HU; Fig. 3). We therefore used a DEI of
0.016 as a cutoff between necrotic core and fibrous plaque to
discriminate plaque with necrotic core.
3.2. Postmortem validation of DECT
HavingestablishedattenuationrangesandDEIs for eachplaque
component, we tested their ability to identify components
ex vivo in 7 coronary arteries. Fifty-four of 77 segments (70%)
contained atherosclerotic plaques with 28 of 77 segments
(36%) containing a necrotic core. Attenuation was sampled
throughoutallnoncalcifiedplaque inco-registeredsegmentsby
using the 100-kV data set. Because SECT attenuation ranges for
necrotic core and fibrous plaque overlapped, no single Houns-
field unit threshold could separate them completely. We
therefore examined the accuracy of 3 different thresholds
(<37 HU, <93 HU, and <138 HU) to define necrotic core. The
threshold of <37 HU was selected because it is less than all
attenuation values found infibrous plaque (37e254HU; Table 1)
and similar to thresholds suggested previously12 (<30 HU)
that prospectively predicts adverse events.2 The interquartile
ranges (IQRs) of necrotic core and fibrous plaque were 29 to
81 HU and 104 to 185 HU, respectively. Thus, <93 HU was
selected as a threshold because it bisects the upper value of
necrotic core IQR (81) and the lower value of fibrous plaque IQR
(104) and hence should include75%necrotic core and exclude
all but25% fibrous tissuewith the lowest attenuation. Finally,
the upper value of the 95th percentile for necrotic core attenu-
ation valueswas 138HU, so<138HUwas selected (Table 1). The
sensitivity, specificity, andaccuracyof theseattenuationvalues
to identify necrotic core were 25%, 98%, and 71%, respectively,
for <37 HU; 50%, 94%, and 78%, respectively, for <93 HU; and
68%, 80%, and 75%, respectively, for <138 HU (Table 2).
We next examined whether DEIs could better discriminate
necrotic core and fibrous tissue compared with 100-kV SECT
on plaques with borderline attenuation values, defined as
>37 HU (the lowest fibrous plaque attenuation) and <219 HUFig. 3 e SECT attenuation at 100 kV and 140 kV and DEIs of VH
attenuation (HU) at 100 kV and 140 kV and DEIs (right) of the VH-
HU, Hounsfield unit; SECT, sle-energy CT; VH-IVUS, virtual hist(the highest necrotic core attenuation). A DEI <0.016 led to
correct detection of necrotic core in 18 of 28 segments, with a
sensitivity, specificity, and accuracy of 64%, 98%, and 86%,
respectively (Table 2). Thus, DEIs improved discrimination of
necrotic core and fibrous tissue compared with SECT (Fig. 4).
3.3. In vivo validation of DECT with VH-IVUS
Better discrimination of necrotic core from fibrous tissue
ex vivo suggests that DECT may better identify these compo-
nents in vivo and thus provide additional coronary CTA fea-
tures of unstable plaques. However, in vivo DECT has poorer
image quality, potentially reducing its clinical utility. We
therefore examined both ability to identify VH-IVUSedefined
plaque components and image quality in 20 patients under-
going DECT. Baseline patient and scan parameters were mean
heart rate of 64  9.4 beats/min, mean scan quality of 1.9  0.7
(scale, 1e4),meannoiseof 16.84.6HU,andmeandose-length
product of 663.7 119.3mGy ∙ cm, giving ameaneffective dose
of 7.8 3.8mSv. In comparisonwith conventional SECT at our
institute, no difference was found in the mean image noise of
DECT vs SECT (16.8  4.6 HU vs 16. 6.2 HU; P ¼ .85), but DECT
displayed significantly lower image quality (mean quality
score, 1.9 vs 3.4). Three-vessel VH-IVUS yielded 60 plaques
from 20 patients. In 18 of the 60 co-registered plaques, DECT
image quality was too poor to allow plaque analysis. Of the
remaining 42 plaques, VH-IVUS found that 31 plaques (74%)
contained significant necrotic core. The most accurate atten-
uation threshold for necrotic core (<93 HU) in the SECT 100-kV
data set detected necrotic core with a 39% sensitivity, 91%
specificity, 92% positive predictive value, 34% negative pre-
dictive value (NPV), and 52% diagnostic accuracy. The addition
of DEIs detected necrotic core with 45% sensitivity, 91% spec-
ificity, 94% positive predictive value, 37% negative predictive
value, and 57% diagnostic accuracy.4. Discussion
Identification of necrotic core is central to identifying high-
risk vulnerable plaques, including thin-cap fibroatheromas-IVUSedefined plaque. Box and whisker plots of CT
IVUSedefined plaque components. DEI, dual-energy index;
ology intravascular ultrasound.
Table 2 e Ex vivo diagnostic accuracy of CT characterization of necrotic core.
Sensitivity correctly
identified, % (95% CI) [n/N]
Specificity correctly
excluded, % (95% CI) [n/N]
PPV, % (95% CI) NPV, % (95% CI) Accuracy,
% (95% CI)
SECT
<37 HU 25 (11e45) [7/28] 98 (89e100) [48/49] 88 (47e98) 70 (57e80) 71 (60e81)
<93 HU 50 (31e69) [14/28] 94 (83e99) [46/49] 82 (57e96) 77 (64e87) 78 (67e87)
<138 HU 68 (48e84) [19/28] 80 (66e90) [39/49] 66 (46e82) 81 (67e91) 75 (63e84)
DECT (if HU < 219)
DEI < 0.016 64 (44e81) [18/28] 98 (89e100) [48/49] 95 (74e99) 83 (71e91) 86 (76e93)
DECT, dual-energy CT; DEI, dual-energy index; NPV, negative predictive value; PPV, positive predictive value; SECT, single-energy CT.
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IVUS.11 Coronary CTA can identify lipid pools as large areas of
hypodense plaque (>2 mm2),13 and low-attenuation plaque
surrounded by higher attenuation noncalcified plaque; the
napkin-ring sign is associated with larger necrotic cores on
histology.14 However, this CT sign still only identified 44%
of optical coherence tomography defined TCFA.15 Better
discrimination of necrotic core from fibrous tissue by CTA is
required if it is to bemore widely used as a tool for patient risk
stratification. The spatial resolution of modern CT scanners at
0.4 mm is sufficient to detect average-sized necrotic cores in
most ruptured plaques (2.2 mm2) and nonruptured TCFAs
(1.1 mm2).16 Thus, detecting necrotic core depends on better
discrimination from fibrous tissue.
We first defined attenuation ranges that represent different
plaque components by using co-registered VH-IVUS. Although
VH-IVUS has some limitations, we recently found diagnostic
accuracies of >74% for VH-IVUS to classify all plaques.9 SECT
showed significant overlap between attenuation ranges of
necrotic core and fibrous plaque. At diagnostic energies, x-ray
attenuation depends on both photoelectric absorption, which
depends on atomic number, and Compton scatter, whichFig. 4 e DECT imaging compared with postmortem histology. Vo
coronary artery with attenuation sampling of noncalcified plaq
attenuation values are above the threshold required to classify n
NC confirmed by histology (right). DECT, dual-energy CT; DEI, d
necrotic core.depends on density of the material. These interactions alter
according to the delivered energy. Lipid-rich necrotic core has
a lower atomic number than calcium in plaque and a lower
density than fibrous tissue and resulted in both the lowest
attenuation values and the smallest change in attenuation
at different energies. With the use of the attenuation at 2
energies to create DEIs we found that the DEI of necrotic core
was significantly lower than fibrous plaque and calcified pla-
que, and, importantly, there was no overlap in necrotic core
and fibrous plaque DEIs. This is in contrast to a previous
postmortem coronary DECT study by Barreto et al7 which
found no significant difference. Like us, Barreto et al7 found a
significant change in attenuation of fibrous plaque at different
x-ray energies but not lipid-rich necrotic core. However,
although Barreto et al7 found that the DEI of lipid-rich plaque
was lower than fibrous plaque, it was not statistically signifi-
cant. Thismay be due to a number of factors. First, only 3 lipid-
rich plaque areas were sampled, resulting in reduced power to
detect any difference. In addition, lipid-rich plaque was
located on 5-mm thick histology samples, orders of magnitude
thinner than the reconstructed slice thickness of coronary
CTA. If the lipid-rich plaquewas small, the area sampled by CTlume-rendered DECT reconstruction (middle) of postmortem
ue at 100 kV (158 HU) and 140 kV (153 HU) (left). These
ecrotic core; however, the DEI (0.002) correctly identifies the
ual-energy index; HU, Hounsfield unit; LU, lumen; NC,
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values from VH-IVUS, requiring a large (>10% plaque volume)
confluent necrotic core on a VH-IVUS slice (approximately
150 mm). This comparable sample sizes may make it more
likely that the CT sampled area contained predominantly
necrotic core rather than other plaque types.
We used DEIs to examine the ability of DECT to identify
necrotic core compared with histology in postmortem coro-
nary arteries. Previous SECT studies defined necrotic corewith
a low attenuation threshold (30 HU) to prevent false posi-
tives.2,12 Indeed, <37 HU gave excellent specificity (98%) but
low sensitivity (25%), whereas <138 HU increased sensitivity
but markedly reduced specificity. The highest diagnostic
accuracy was achieved by using <93 HU; however, the use of
DECT improved both sensitivity and specificity for detecting
necrotic core.
Finally, we examined the ability of DECT to identify plaque
components against VH-IVUS in vivo. The use of dual-source
CT in dual-energy mode to create 2 independent data sets
reduces its temporal resolution from 83 milliseconds to
165 milliseconds, but whether this negates any additional
information gained from attenuation changes detected by
DECT is unknown. DECT scans were performed with retro-
spective acquisitions, explaining the relatively high radiation
exposures albeit still lower than median doses reported in
clinical practice.17 Although DECT produced a modest benefit
in diagnostic accuracy to differentiate necrotic core vs SECT,
the clinical utility of DECT was severely limited by loss of
image quality.
This study was designed to examine the ability of DECT to
identify plaque components, specifically to discriminate
necrotic core from fibrous tissue. However, there are limita-
tions to our study. First, the same patients were used for both
derivation and validation (although analyzed per cross section
vs per plaque). Diagnostic accuracy results may be worse if
validation is applied in a completely independent sample.
Second, blooming artifact of high attenuation structures
means that identifying true boundaries of calcified plaque can
be difficult. Combined with reduced quality of in vivo DECT,
this may affect accuracy of attenuation values obtained in
some calcified plaque areas and may explain the similar DEIs
of lumen and calcified plaque despite differences in atomic
numbers of iodine and calcium. Image quality may be better
with slower heart rates, although the acquisition protocols
used reflect current clinical practice. Third, DEI differences
may be greater if 80 kV, not 100 kV, was used as the lower
x-ray energy. However, the use of 80 kV in our in vivo popu-
lationwould increase image noisewith potential loss of image
interpretability. Fourth, ex vivo validationwas based on only 7
coronary arteries; nevertheless, these arteries yielded 77 seg-
ments, including 28 with necrotic core. Fifth, the accuracy of
SECT was tested with the use of fixed attenuation thresholds.
However, attenuation of coronary structures may alter,
depending on body habitus, and attenuation of plaque may
vary according to adjacent contrast intensity, especially in
more vascular plaques with developed vasa vasorum. The
accuracy of SECT may be increased if attenuation thresholds
were standardized according to aortic attenuation and modi-
fied to take into account luminal contrast intensity. Finally,
the clinical study compared SECT with DECT. However,because of constraints on radiation exposure, the 100-kV data
set fromDECTwas used to represent SECT. Although 100 kV is
a recognized voltage for clinical use,17 the temporal resolution
in the 100-kV DECT data set is lower than in conventional
SECT. The diagnostic accuracy to detect necrotic core by using
DEIs was lower in vivo than in postmortem samples. In vivo
images can be degraded by mechanisms such as beam hard-
ening, scatter from adjacent structures, and the effect of
the lower temporal resolution of DECT on moving coronary
arteries. Although newer dual-source, DECT scanners have
improved temporal resolution,18 whether this negates the loss
of accuracy of DECT plaque analysis in vivo is unknown.
In summary, coronary CTA imaging with 2 energy levels
permitted better resolution of necrotic core and fibrous plaque
than single-energy coronary CTA. Dual energy also improves
accuracy in classifying plaque components ex vivo. Although
this suggests that DECT may identify vulnerable atheroscle-
rotic plaques with more precision than single energy, its
clinical usefulness in our study was limited by inferior tem-
poral resolution. Nevertheless, improvements in CT technol-
ogywith better temporal resolutionmean that DECT is worthy
of future evaluation in prospective trials to aid prediction of
future coronary events.r e f e r e n c e s
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